Literature DB >> 4085148

Immunology of streptokinase in human subjects.

K McGrath, R Patterson.   

Abstract

Streptokinase is an effective thrombolytic agent used in various thrombotic diseases. Until recently, allergic reactions have not been well characterized. We report the clinical and immunologic correlations of three types of reactions to streptokinase (S) in man. These include IgE antibody to S which mediates anaphylaxis and immediate-type skin reactivity to S. This skin test may be predictive of those at risk for anaphylaxis. IgG antibody and S form antigen-antibody complexes which result in toxic immune complex disease including skin, renal and joint symptoms. This human response simulates the animal model of immune complex disease reported over two decades ago. Lymphocyte mediated reactions include local delayed cutaneous reactions with systemic malaise correlating with in vitro lymphocyte reactions to S. An immune response of rising IgE, immediate-type skin reactivity and rising IgG antibody occurred in two physicians volunteering for skin test analysis to S.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085148      PMCID: PMC1577433     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Enzyme linked immunosorbent assay (ELISA) for IgG and IgE antibodies to protein and polysaccharide antigens of Aspergillus fumigatus.

Authors:  R Sepulveda; J L Longbottom; J Pepys
Journal:  Clin Allergy       Date:  1979-07

3.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

4.  [Plasmacytosis following thrombolytic streptokinase therapy].

Authors:  P W Straub; J Boersma; K Rhyner; K Schihin
Journal:  Schweiz Med Wochenschr       Date:  1974-12-14

5.  Treatment of deep-vein thrombosis with streptokinase.

Authors:  V V Kakkar; C Flanc; M J O'Shea; P T Flute; C T Howe; M B Clarke
Journal:  Br J Surg       Date:  1969-03       Impact factor: 6.939

6.  Thrombolysis of acute or subacute nonembolic arterial thrombosis.

Authors:  F A Reichle; N S Rao; K H Chang; V Marder; K Algazy
Journal:  J Surg Res       Date:  1977-03       Impact factor: 2.192

7.  Serum sickness following streptokinase therapy.

Authors:  W G Totty; T Romano; G M Benian; L A Gilula; L A Sherman
Journal:  AJR Am J Roentgenol       Date:  1982-01       Impact factor: 3.959

8.  Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy.

Authors:  V J Marder; R L Soulen; V Atichartakarn; A Z Budzynski; S Parulekar; J R Kim; N Edward; J Zahavi; K M Algazy
Journal:  J Lab Clin Med       Date:  1977-05

9.  Streptokinase in central retinal vein occlusion: a controlled clinical trial.

Authors:  E M Kohner; J E Pettit; A M Hamilton; C J Bulpitt; C T Dollery
Journal:  Br Med J       Date:  1976-03-06

10.  Effects of intracoronary streptokinase in acute myocardial infarction.

Authors:  M J Cowley; A Hastillo; G W Vetrovec; M L Hess
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

View more
  5 in total

1.  Binase does not induce polyclonal T-cell response.

Authors:  P V Zelenikhin; G V Cherepnev; F Kern; O N Ilinskaia
Journal:  Dokl Biol Sci       Date:  2006 Mar-Apr

2.  Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.

Authors:  Y Birnbaum; B Strasberg; E Rechavia; Y Neuman; B Stahl
Journal:  West J Med       Date:  1993-04

3.  Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.

Authors:  S Patel; S Jalihal; D P Dutka; G K Morris
Journal:  Br Heart J       Date:  1993-08

4.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08

Review 5.  Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors:  J Nazari; R Davison; K Kaplan; D Fintel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.